Home
Medicines Access Review — Implementation

Medicines Access Review — Implementation

No formal announcement of progress against the ten recommendations of the 2025 Medicines Access Review has been published during May 2026.

DoH NI Consultations

A DoH NI consultation opened on 11 May 2026 relating to proposed changes to UK-wide medicines legislation governing the definition of gene therapies, led by the MHRA. This is not directly related to high cost drugs commissioning governance but is relevant to the broader medicines regulatory landscape.1

References

1.  Consultations — Northern Ireland Executive (gene therapy MHRA consultation, 11 May 2026). Northern Ireland Executive. 11 May 2026. https://www.northernireland.gov.uk/consultations

Add Your Heading Text Here

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.